ArticleThe Lancet. Oncology2018
Tivantinib for advanced hepatocellular carcinoma: is MET still a viable target?
Colin D Weekes et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this paperpooled itcites it
ArticleThe Lancet. Oncology2018
Colin D Weekes et al.PubMed ↗Publisher ↗
No numbers read from the abstract.